-
Discovery & Optimization of New Anti-migraine Peptides
The identification in recent years of the strong connection between neuroactive peptides and migraine has greatly incentivized further research and development of small protein molecules for treatment and prevention of this debilitating disorder. Correspondingly the demand for more efficient methods of purifying peptides has increased, especially in reversed phase chromatography, which has been shown to be very well suited to the task with excellent recovery and resolution. Reverse phase method development for this application, however, requires careful consideration of key parameters such as sample loading and stationary phase particle size.
Our featured guest speaker on this topic is Dr. Christopher R. Coxon, Institute of Chemical Sciences, School of Engineering and Physical Sciences, H...
published: 08 Apr 2021
-
Migraine medications ~pharmacology~
What are migraine medications? Migraine medications include a variety of drugs used to treat a specific type of headache called migraine.
Find our full video library only on Osmosis: http://osms.it/more.
Join millions of current and future clinicians who learn by Osmosis, along with hundreds of universities around the world who partner with Osmosis from Elseiver to make medical and health education more engaging and efficient. We have unparalleled tools and materials to prepare you for success in school, on your board exams, and as a future clinician. Sign up for a free trial at http://osms.it/more. If you're interested in exploring an institutional partnership, visit osmosis.org/educators to request a personalized demo.
Follow us on social:
Facebook: http://osms.it/facebook
Twitter: h...
published: 23 Jan 2024
-
Migraine Science Collaborative Neuroscience Poster Competition 2022
The second annual Migraine Science Collaborative (MSC) Neuroscience Poster Competition was held via Zoom on November 30, 2022. Learn more at https://migrainecollaborative.org/the-2022-migraine-science-collaborative-virtual-poster-contest
With this annual competition, we strive to highlight some of the best research projects by some of the brightest emerging scientists that either directly advance our knowledge of migraine disease or indirectly, because, while some research projects may not have been designed with migraine disease in mind, they all address issues that have a bearing on one or more aspects of the complex biology of migraine disease.
Category Winners:
Migraine: Micah Johnson (graduate student, University of Iowa) - 00:02:25
Physiology/Diagnosis/Therapeutics. Seifaldin Se...
published: 12 Dec 2022
-
Antimigraine part 2
published: 17 May 2023
-
What is the best treatment for a migraine?
ABC News chief medical correspondent Dr. Jen Ashton answers your health questions and shares her daily prescription for wellness.
SUBSCRIBE to GMA3's YouTube page:
https://bit.ly/3kNlst8
VISIT GMA's homepage:
https://abc.com/shows/gma3-what-you-need-to-know
FOLLOW GMA3:
Facebook: https://www.facebook.com/abcgma3
Twitter: https://twitter.com/abcgma3
Instagram: https://instagram.com/abcgma3
#GMA3
published: 28 Jun 2022
-
Getting Ahead of Migraine: Integrating Preventive Strategies into Migraine Care
Migraine is a debilitating condition with profound effects on individuals’ quality of life, accounting for five to nine millionprimary care visits each year. It is estimated that 38% of sufferers could benefit from preventative treatment, but few are currently using them nor are their healthcare providers discussing these options with them. Consequently, there is great interest in emerging data about calcitonin gene-related peptide (CGRP) agents as novel options for migraine prevention and the benefits they may provide to patients.Access more information about this activity here: https://www.cmeoutfitters.com/transfers/cm/?ID=27392
published: 09 Aug 2018
-
Anti Migraine and drugs for Trigeminal neuralgia Lecture@16
This lecture include
1. Discuss the action, contraindication and side effects of Antimigraine and Trigeminal neuralgia
2. Identify most commonly used drugs for migraine and Trigeminal neuralgia
3. State the major nursing care if client is using Anti migraine and Trigeminal neuralgia.
4. Calculate the drug dosage accurately for oral anti migraine and drugs for trigeminal neuralgia.
published: 04 May 2020
-
Expert Series Webinar: Why Isn't My Migraine Treatment Working?
What should you do when your migraine treatment stops working? What happens when multiple treatments fail you? In this webinar, AMF Chair Dr. Lawrence Newman presents common cases of treatment failure and panelists Drs. Cynthia Armand, Thomas Berk and Laine Green share their insights as providers and help “solve” these cases.
The American Migraine Foundation would like to thank Move Against Migraine Sponsors Amgen and Eli Lilly and Company for their support.
Resources mentioned in this webinar include:
Find a Doctor Tool: https://americanmigrainefoundation.org/find-a-doctor
Downloadable Guide to Speaking to Your Doctor: https://info.americanmigrainefoundation.com/talking-to-your-doctor-about-migraine
For more information and resources visit our website at https://americanmigrainefound...
published: 11 Jan 2022
-
Pharmacology- Migraine Treatment- Autocoids Pharma MADE EASY!
*metoclopramide is a 5HT4 agonist not antagonist 🚨CORRECT THIS *
Drugs used in Migraine
Autocoid pharmacology
Easy Review
published: 19 Jul 2019
-
WNSW PHN Webinar: Headache Work Up and Migraine Update
Presented by Dr Emma Blackwood, Consultant Neurologist, on Tuesday August 23, 2022, this webinar includes information on managing a headache patient, including when to refer, when to investigate further, and when to commence medication. An update on new medications for migraine is also provided.
While the Australian Government contributed funding for this presentation, it has not reviewed the content and is not responsible for any injury, loss or damage however arising from the use of or reliance on the information provided herein.
published: 26 Aug 2022
1:07:36
Discovery & Optimization of New Anti-migraine Peptides
The identification in recent years of the strong connection between neuroactive peptides and migraine has greatly incentivized further research and development ...
The identification in recent years of the strong connection between neuroactive peptides and migraine has greatly incentivized further research and development of small protein molecules for treatment and prevention of this debilitating disorder. Correspondingly the demand for more efficient methods of purifying peptides has increased, especially in reversed phase chromatography, which has been shown to be very well suited to the task with excellent recovery and resolution. Reverse phase method development for this application, however, requires careful consideration of key parameters such as sample loading and stationary phase particle size.
Our featured guest speaker on this topic is Dr. Christopher R. Coxon, Institute of Chemical Sciences, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh, UK. Dr. Coxon is also one of the co-authors of our Chromatography Application Note AN115: “Reversed Phase Flash Chromatography Purification of Peptide-Peptoid Hybrids.”
The moderator for this event is Josh Lovell, Applications Specialist at Teledyne ISCO, responsible for helping customers solve challenging problems in analytical, flash, and preparatory chromatography applications.
In this webinar Dr. Coxon will discuss the latest treatments for migraine and the evidence showing peptides could be the best way forward. He will also describe his team’s work in discovering new treatments and how the latest peptide-related research technologies are being employed.
• Peptides as the future of migraine treatment and prevention
• Key considerations for the development and purification of peptide targets
• How reversed phase flash chromatography enables high resolution purification of peptides where there are closely eluting impurities
• The right mobile phase for purifying peptides at high resolution
• Sample loading and stationary phase particle size considerations
• The role of Teledyne ISCO flash chromatography systems in this research
From this 45-minute presentation plus interactive Q&A; session, attendees will gain stronger insight into the role of small protein molecules, how to better purify them with reverse phase flash chromatography methods, and how to quickly solve the most common method development problems.
https://wn.com/Discovery_Optimization_Of_New_Anti_Migraine_Peptides
The identification in recent years of the strong connection between neuroactive peptides and migraine has greatly incentivized further research and development of small protein molecules for treatment and prevention of this debilitating disorder. Correspondingly the demand for more efficient methods of purifying peptides has increased, especially in reversed phase chromatography, which has been shown to be very well suited to the task with excellent recovery and resolution. Reverse phase method development for this application, however, requires careful consideration of key parameters such as sample loading and stationary phase particle size.
Our featured guest speaker on this topic is Dr. Christopher R. Coxon, Institute of Chemical Sciences, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh, UK. Dr. Coxon is also one of the co-authors of our Chromatography Application Note AN115: “Reversed Phase Flash Chromatography Purification of Peptide-Peptoid Hybrids.”
The moderator for this event is Josh Lovell, Applications Specialist at Teledyne ISCO, responsible for helping customers solve challenging problems in analytical, flash, and preparatory chromatography applications.
In this webinar Dr. Coxon will discuss the latest treatments for migraine and the evidence showing peptides could be the best way forward. He will also describe his team’s work in discovering new treatments and how the latest peptide-related research technologies are being employed.
• Peptides as the future of migraine treatment and prevention
• Key considerations for the development and purification of peptide targets
• How reversed phase flash chromatography enables high resolution purification of peptides where there are closely eluting impurities
• The right mobile phase for purifying peptides at high resolution
• Sample loading and stationary phase particle size considerations
• The role of Teledyne ISCO flash chromatography systems in this research
From this 45-minute presentation plus interactive Q&A; session, attendees will gain stronger insight into the role of small protein molecules, how to better purify them with reverse phase flash chromatography methods, and how to quickly solve the most common method development problems.
- published: 08 Apr 2021
- views: 531
12:16
Migraine medications ~pharmacology~
What are migraine medications? Migraine medications include a variety of drugs used to treat a specific type of headache called migraine.
Find our full video l...
What are migraine medications? Migraine medications include a variety of drugs used to treat a specific type of headache called migraine.
Find our full video library only on Osmosis: http://osms.it/more.
Join millions of current and future clinicians who learn by Osmosis, along with hundreds of universities around the world who partner with Osmosis from Elseiver to make medical and health education more engaging and efficient. We have unparalleled tools and materials to prepare you for success in school, on your board exams, and as a future clinician. Sign up for a free trial at http://osms.it/more. If you're interested in exploring an institutional partnership, visit osmosis.org/educators to request a personalized demo.
Follow us on social:
Facebook: http://osms.it/facebook
Twitter: http://osms.it/twitter
Instagram for med: http://osms.it/instagram
Instagram for nursing: https://osms.it/ignursing
TikTok: https://osms.it/tiktok
Linkedin: https://osms.it/linkedin
Our Vision: Everyone who cares for someone will learn by Osmosis.
Our Mission: To empower the world’s clinicians and caregivers with the best learning experience possible. Learn more here: http://osms.it/mission
Medical disclaimer: Osmosis from Elsevier does not provide medical advice. Osmosis from Elsevier and the content available on the Osmosis from Elsevier properties (Osmosis.org, YouTube, and other channels) do not provide a diagnosis or other recommendation for treatment and are not a substitute for the professional judgment of a healthcare professional in diagnosis and treatment of any person or animal. The determination of the need for medical services and the types of healthcare to be provided to a patient are decisions that should be made only by a physician or other licensed healthcare provider. Always seek the advice of a physician or other qualified healthcare professional with any questions you have regarding a medical condition.
© 2024 Elsevier. All rights reserved.
https://wn.com/Migraine_Medications_~Pharmacology~
What are migraine medications? Migraine medications include a variety of drugs used to treat a specific type of headache called migraine.
Find our full video library only on Osmosis: http://osms.it/more.
Join millions of current and future clinicians who learn by Osmosis, along with hundreds of universities around the world who partner with Osmosis from Elseiver to make medical and health education more engaging and efficient. We have unparalleled tools and materials to prepare you for success in school, on your board exams, and as a future clinician. Sign up for a free trial at http://osms.it/more. If you're interested in exploring an institutional partnership, visit osmosis.org/educators to request a personalized demo.
Follow us on social:
Facebook: http://osms.it/facebook
Twitter: http://osms.it/twitter
Instagram for med: http://osms.it/instagram
Instagram for nursing: https://osms.it/ignursing
TikTok: https://osms.it/tiktok
Linkedin: https://osms.it/linkedin
Our Vision: Everyone who cares for someone will learn by Osmosis.
Our Mission: To empower the world’s clinicians and caregivers with the best learning experience possible. Learn more here: http://osms.it/mission
Medical disclaimer: Osmosis from Elsevier does not provide medical advice. Osmosis from Elsevier and the content available on the Osmosis from Elsevier properties (Osmosis.org, YouTube, and other channels) do not provide a diagnosis or other recommendation for treatment and are not a substitute for the professional judgment of a healthcare professional in diagnosis and treatment of any person or animal. The determination of the need for medical services and the types of healthcare to be provided to a patient are decisions that should be made only by a physician or other licensed healthcare provider. Always seek the advice of a physician or other qualified healthcare professional with any questions you have regarding a medical condition.
© 2024 Elsevier. All rights reserved.
- published: 23 Jan 2024
- views: 22942
1:46:12
Migraine Science Collaborative Neuroscience Poster Competition 2022
The second annual Migraine Science Collaborative (MSC) Neuroscience Poster Competition was held via Zoom on November 30, 2022. Learn more at https://migrainecol...
The second annual Migraine Science Collaborative (MSC) Neuroscience Poster Competition was held via Zoom on November 30, 2022. Learn more at https://migrainecollaborative.org/the-2022-migraine-science-collaborative-virtual-poster-contest
With this annual competition, we strive to highlight some of the best research projects by some of the brightest emerging scientists that either directly advance our knowledge of migraine disease or indirectly, because, while some research projects may not have been designed with migraine disease in mind, they all address issues that have a bearing on one or more aspects of the complex biology of migraine disease.
Category Winners:
Migraine: Micah Johnson (graduate student, University of Iowa) - 00:02:25
Physiology/Diagnosis/Therapeutics. Seifaldin Selim Aldalil (undergraduate student, Sewanee: The University of the South) - 00:44:46
Pain and Epilepsy: Giuseppe Cataldo (City University of New York) - 00:59:45
Special Sensory Systems and Comorbidities: Shafaqat Rahman (PhD student, University of Rochester) - 01:24:56
The MSC is a program of the Association of Migraine Disorders.
https://wn.com/Migraine_Science_Collaborative_Neuroscience_Poster_Competition_2022
The second annual Migraine Science Collaborative (MSC) Neuroscience Poster Competition was held via Zoom on November 30, 2022. Learn more at https://migrainecollaborative.org/the-2022-migraine-science-collaborative-virtual-poster-contest
With this annual competition, we strive to highlight some of the best research projects by some of the brightest emerging scientists that either directly advance our knowledge of migraine disease or indirectly, because, while some research projects may not have been designed with migraine disease in mind, they all address issues that have a bearing on one or more aspects of the complex biology of migraine disease.
Category Winners:
Migraine: Micah Johnson (graduate student, University of Iowa) - 00:02:25
Physiology/Diagnosis/Therapeutics. Seifaldin Selim Aldalil (undergraduate student, Sewanee: The University of the South) - 00:44:46
Pain and Epilepsy: Giuseppe Cataldo (City University of New York) - 00:59:45
Special Sensory Systems and Comorbidities: Shafaqat Rahman (PhD student, University of Rochester) - 01:24:56
The MSC is a program of the Association of Migraine Disorders.
- published: 12 Dec 2022
- views: 610
2:08
What is the best treatment for a migraine?
ABC News chief medical correspondent Dr. Jen Ashton answers your health questions and shares her daily prescription for wellness.
SUBSCRIBE to GMA3's YouTube p...
ABC News chief medical correspondent Dr. Jen Ashton answers your health questions and shares her daily prescription for wellness.
SUBSCRIBE to GMA3's YouTube page:
https://bit.ly/3kNlst8
VISIT GMA's homepage:
https://abc.com/shows/gma3-what-you-need-to-know
FOLLOW GMA3:
Facebook: https://www.facebook.com/abcgma3
Twitter: https://twitter.com/abcgma3
Instagram: https://instagram.com/abcgma3
#GMA3
https://wn.com/What_Is_The_Best_Treatment_For_A_Migraine
ABC News chief medical correspondent Dr. Jen Ashton answers your health questions and shares her daily prescription for wellness.
SUBSCRIBE to GMA3's YouTube page:
https://bit.ly/3kNlst8
VISIT GMA's homepage:
https://abc.com/shows/gma3-what-you-need-to-know
FOLLOW GMA3:
Facebook: https://www.facebook.com/abcgma3
Twitter: https://twitter.com/abcgma3
Instagram: https://instagram.com/abcgma3
#GMA3
- published: 28 Jun 2022
- views: 113120
1:29:39
Getting Ahead of Migraine: Integrating Preventive Strategies into Migraine Care
Migraine is a debilitating condition with profound effects on individuals’ quality of life, accounting for five to nine millionprimary care visits each year. It...
Migraine is a debilitating condition with profound effects on individuals’ quality of life, accounting for five to nine millionprimary care visits each year. It is estimated that 38% of sufferers could benefit from preventative treatment, but few are currently using them nor are their healthcare providers discussing these options with them. Consequently, there is great interest in emerging data about calcitonin gene-related peptide (CGRP) agents as novel options for migraine prevention and the benefits they may provide to patients.Access more information about this activity here: https://www.cmeoutfitters.com/transfers/cm/?ID=27392
https://wn.com/Getting_Ahead_Of_Migraine_Integrating_Preventive_Strategies_Into_Migraine_Care
Migraine is a debilitating condition with profound effects on individuals’ quality of life, accounting for five to nine millionprimary care visits each year. It is estimated that 38% of sufferers could benefit from preventative treatment, but few are currently using them nor are their healthcare providers discussing these options with them. Consequently, there is great interest in emerging data about calcitonin gene-related peptide (CGRP) agents as novel options for migraine prevention and the benefits they may provide to patients.Access more information about this activity here: https://www.cmeoutfitters.com/transfers/cm/?ID=27392
- published: 09 Aug 2018
- views: 91
24:13
Anti Migraine and drugs for Trigeminal neuralgia Lecture@16
This lecture include
1. Discuss the action, contraindication and side effects of Antimigraine and Trigeminal neuralgia
2. Identify most commonly used drugs for...
This lecture include
1. Discuss the action, contraindication and side effects of Antimigraine and Trigeminal neuralgia
2. Identify most commonly used drugs for migraine and Trigeminal neuralgia
3. State the major nursing care if client is using Anti migraine and Trigeminal neuralgia.
4. Calculate the drug dosage accurately for oral anti migraine and drugs for trigeminal neuralgia.
https://wn.com/Anti_Migraine_And_Drugs_For_Trigeminal_Neuralgia_Lecture_16
This lecture include
1. Discuss the action, contraindication and side effects of Antimigraine and Trigeminal neuralgia
2. Identify most commonly used drugs for migraine and Trigeminal neuralgia
3. State the major nursing care if client is using Anti migraine and Trigeminal neuralgia.
4. Calculate the drug dosage accurately for oral anti migraine and drugs for trigeminal neuralgia.
- published: 04 May 2020
- views: 221
1:01:04
Expert Series Webinar: Why Isn't My Migraine Treatment Working?
What should you do when your migraine treatment stops working? What happens when multiple treatments fail you? In this webinar, AMF Chair Dr. Lawrence Newman pr...
What should you do when your migraine treatment stops working? What happens when multiple treatments fail you? In this webinar, AMF Chair Dr. Lawrence Newman presents common cases of treatment failure and panelists Drs. Cynthia Armand, Thomas Berk and Laine Green share their insights as providers and help “solve” these cases.
The American Migraine Foundation would like to thank Move Against Migraine Sponsors Amgen and Eli Lilly and Company for their support.
Resources mentioned in this webinar include:
Find a Doctor Tool: https://americanmigrainefoundation.org/find-a-doctor
Downloadable Guide to Speaking to Your Doctor: https://info.americanmigrainefoundation.com/talking-to-your-doctor-about-migraine
For more information and resources visit our website at https://americanmigrainefoundation.org
Join the migraine community:
Facebook: https://www.facebook.com/americanmigrainefoundation/
Move Against Migraine Facebook support group: https://www.facebook.com/groups/moveagainstmigraine
Instagram: https://www.instagram.com/amfmigraine/
Twitter: https://twitter.com/amfmigraine
LinkedIn: https://www.linkedin.com/company/americanmigrainefoundation/
https://wn.com/Expert_Series_Webinar_Why_Isn't_My_Migraine_Treatment_Working
What should you do when your migraine treatment stops working? What happens when multiple treatments fail you? In this webinar, AMF Chair Dr. Lawrence Newman presents common cases of treatment failure and panelists Drs. Cynthia Armand, Thomas Berk and Laine Green share their insights as providers and help “solve” these cases.
The American Migraine Foundation would like to thank Move Against Migraine Sponsors Amgen and Eli Lilly and Company for their support.
Resources mentioned in this webinar include:
Find a Doctor Tool: https://americanmigrainefoundation.org/find-a-doctor
Downloadable Guide to Speaking to Your Doctor: https://info.americanmigrainefoundation.com/talking-to-your-doctor-about-migraine
For more information and resources visit our website at https://americanmigrainefoundation.org
Join the migraine community:
Facebook: https://www.facebook.com/americanmigrainefoundation/
Move Against Migraine Facebook support group: https://www.facebook.com/groups/moveagainstmigraine
Instagram: https://www.instagram.com/amfmigraine/
Twitter: https://twitter.com/amfmigraine
LinkedIn: https://www.linkedin.com/company/americanmigrainefoundation/
- published: 11 Jan 2022
- views: 979
6:55
Pharmacology- Migraine Treatment- Autocoids Pharma MADE EASY!
*metoclopramide is a 5HT4 agonist not antagonist 🚨CORRECT THIS *
Drugs used in Migraine
Autocoid pharmacology
Easy Review
*metoclopramide is a 5HT4 agonist not antagonist 🚨CORRECT THIS *
Drugs used in Migraine
Autocoid pharmacology
Easy Review
https://wn.com/Pharmacology_Migraine_Treatment_Autocoids_Pharma_Made_Easy
*metoclopramide is a 5HT4 agonist not antagonist 🚨CORRECT THIS *
Drugs used in Migraine
Autocoid pharmacology
Easy Review
- published: 19 Jul 2019
- views: 71351
55:35
WNSW PHN Webinar: Headache Work Up and Migraine Update
Presented by Dr Emma Blackwood, Consultant Neurologist, on Tuesday August 23, 2022, this webinar includes information on managing a headache patient, including ...
Presented by Dr Emma Blackwood, Consultant Neurologist, on Tuesday August 23, 2022, this webinar includes information on managing a headache patient, including when to refer, when to investigate further, and when to commence medication. An update on new medications for migraine is also provided.
While the Australian Government contributed funding for this presentation, it has not reviewed the content and is not responsible for any injury, loss or damage however arising from the use of or reliance on the information provided herein.
https://wn.com/Wnsw_Phn_Webinar_Headache_Work_Up_And_Migraine_Update
Presented by Dr Emma Blackwood, Consultant Neurologist, on Tuesday August 23, 2022, this webinar includes information on managing a headache patient, including when to refer, when to investigate further, and when to commence medication. An update on new medications for migraine is also provided.
While the Australian Government contributed funding for this presentation, it has not reviewed the content and is not responsible for any injury, loss or damage however arising from the use of or reliance on the information provided herein.
- published: 26 Aug 2022
- views: 98